Biogen Inc. (BIIB)

Healthcare · Drug Manufacturers General · NASDAQ

S&P 500

Biogen Inc. (BIIB) is a Healthcare company in the Drug Manufacturers General industry. It has a market capitalization of $30.72B, a trailing price-to-earnings ratio of 14.9 and a free-cash-flow yield of 6.4%. Over the most recent reported fiscal year, revenue grew 2.2% and free cash flow per share fell 22.4%.

Market cap	$30.72B
Trailing P/E	14.9
FCF yield	6.4%
Revenue growth (YoY)	+2.2%
EPS growth (YoY)	-7.2%
FCF/share growth (YoY)	-22.4%
Exchange	NASDAQ
Sector	Healthcare
Industry	Drug Manufacturers General

Explore live BIIB data on Nama Insights →

Recent Congressional trades

Biogen Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Jul 2, 2026
Maria Elvira Salazar	House	Sell	$15,001	Jul 1, 2026
Maria Elvira Salazar	House	Buy	$1,001 - $15,000	Jun 1, 2026
Maria Elvira Salazar	House	Buy	$1,001 - $15,000	Jun 1, 2026
Maria Elvira Salazar	House	Buy	$50,001	Jun 1, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Feb 11, 2026
Kathy Manning	House	Sell	$1,001 - $15,000	Sep 6, 2022
Josh Gottheimer	House	Sell	$1,001 - $15,000	Apr 11, 2022
Josh Gottheimer	House	Buy	$1,001 - $15,000	Nov 4, 2021
Josh Gottheimer	House	Buy	$1,001 - $15,000	Jul 12, 2021
Peter Meijer	House	Sell	$15,001 - $50,000	Feb 19, 2021
Christopher L. Jacobs	House	Sell	$1,001 - $15,000	Feb 10, 2021